Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality.

Part of paid clinical trials in Scottsdale, Arizona.

Sponsor
Fairtility
Study ID
NCT06928337
Status
Recruiting
Apply to this trial

Conditions

  • Fertility Disorders

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • AI evaluation of oocytes. — DEVICE
    AI evaluation of oocytes inside a time-lapse incubator.

Study Details

This data collection protocol is aimed to allow the reliable and robust development (training, verification, and validations) of CHLOE technology-based applications as well as improve the machine learning stage of released devices/applications. Additionally, a simulated use assessments will be conducted to ensure the correct and easy use of the CHLOE applications.

Key Dates

Start date
May 1, 2025
Status verified
Apr 2025
Primary completion
May 1, 2026
Completion
May 1, 2026

Study Design

Enrollment
350 participants (estimated)

Primary Outcome Measure

Area under the curve (AUC) will be quantified using logistic regression to assess CHLOE OQ's prediction of blastulation. [ Time Frame: 7 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The World Egg and Sperm BankScottsdaleArizona85260
Ariel Lovato
[email protected]
1-602-678-1906

Find similar trials in Scottsdale, AZ

By research site
The World Egg and Sperm Bank· Scottsdale, AZ

Related Studies